Visalytics
Visalytics
approved EB-2 (NIW)

Research Fellow

Molecular Biology · China · 2025-04-10

Processing Time
312 days
Decision Date
2025-04-10
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research into uncovering the genetic mechanisms that cause resistance to cancer therapies. Using state-of-the-art screening techniques, the work aims to accelerate the development of next-generation combination therapies to overcome tumor resistance. The endeavor focuses on exploring gene targets affecting immunotherapy response and examining the molecular behavior of oncogenic proteins.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses multidrug resistance, which is responsible for the majority of cancer treatment failures globally.

2 Well-positioned to Advance the Endeavor Met

The petitioner has an advanced background in biochemistry and a record of highly cited publications in top-tier journals like Signal Transduction and Targeted Therapy.

3 Balance of Interests Met

The importance of impactful scientific research in public health justifies waiving the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's prolific academic portfolio, including 6 peer-reviewed journal articles, 1 preprint, and 1 patent application. Evidence showed 369 citations and at least 13 completed peer reviews for journals like BMC Cancer. The case satisfied all three Dhanasar prongs by demonstrating the national importance of tackling cancer treatment failure and the petitioner's high standing in the field.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Judging Experience
Original Contributions

Similar Cases

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Missouri 49 days 2025-04-01
The petitioner proposes to identify novel therapeutic targets to improve personalized medicine and enhance treatment outcomes for cancer patients. Her work focuses on addressing drug resistance in oncology by integrating synthetic biology, protein engineering, and tumor signaling analysis to develop optimized drug delivery methods.
View Case

Research Fellow

Biotechnology · China

WeGreened EB-2 (NIW) approved
Massachusetts 330 days 2025-04-14
The petitioner proposes to identify molecular mechanisms underlying chemotherapeutic resistance and develop molecular diagnostics for solid tumors. This work involves investigating patient-derived organoid cultures, CRISPR engineering, and high-throughput drug testing to improve early cancer detection and patient outcomes.
View Case

Others

Biotechnology · India

WeGreened EB-2 (NIW) approved
195 days 2022-05-06
The petitioner proposes to continue developing genomic screening platforms and gene therapy-based approaches to facilitate the design of novel treatment modalities for cancer. This work focuses on identifying genetic factors that contribute to cancer development and progression using state-of-the-art molecular methods.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-10.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 312 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist